Marcus J G W Ladds
Marcus J G W Ladds
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
2SciLifeLab, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Tomtebodavägen 23, SE-171 21 Stockholm, Sweden
1,2,#,
Ingeborg M M van Leeuwen
Ingeborg M M van Leeuwen
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
1,#,
Catherine J Drummond
Catherine J Drummond
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
1,#,
Su Chu
Su Chu
3Division of Hematology and Oncology, Comprehensive Cancer Center, 1720 2nd Avenue South, NP2540, Birmingham, AL 35294-3300 USA
3,
Alan R Healy
Alan R Healy
4School of Chemistry and Biomedical Sciences Research Complex, University of St. Andrews and EaStCHEM, St. Andrews, Fife, Scotland KY16 9ST UK
4,
Gergana Popova
Gergana Popova
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
1,
Andrés Pastor Fernández
Andrés Pastor Fernández
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
1,
Tanzina Mollick
Tanzina Mollick
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
2SciLifeLab, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Tomtebodavägen 23, SE-171 21 Stockholm, Sweden
1,2,
Suhas Darekar
Suhas Darekar
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
2SciLifeLab, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Tomtebodavägen 23, SE-171 21 Stockholm, Sweden
1,2,
Saikiran K Sedimbi
Saikiran K Sedimbi
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
2SciLifeLab, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Tomtebodavägen 23, SE-171 21 Stockholm, Sweden
1,2,
Marta Nekulova
Marta Nekulova
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
5RECAMO, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 65653 Brno, Czech Republic
1,5,
Marijke C C Sachweh
Marijke C C Sachweh
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
1,
Johanna Campbell
Johanna Campbell
6Centre for Oncology and Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, Tayside DD1 9SY UK
6,
Maureen Higgins
Maureen Higgins
6Centre for Oncology and Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, Tayside DD1 9SY UK
6,
Chloe Tuck
Chloe Tuck
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
1,
Mihaela Popa
Mihaela Popa
7Centre for Cancer Biomarkers, CCBIO, Department of Clinical Science, Hematology Section, University of Bergen, 5021 Bergen, Norway
7,
Mireia Mayoral Safont
Mireia Mayoral Safont
7Centre for Cancer Biomarkers, CCBIO, Department of Clinical Science, Hematology Section, University of Bergen, 5021 Bergen, Norway
7,
Pascal Gelebart
Pascal Gelebart
7Centre for Cancer Biomarkers, CCBIO, Department of Clinical Science, Hematology Section, University of Bergen, 5021 Bergen, Norway
7,
Zinayida Fandalyuk
Zinayida Fandalyuk
7Centre for Cancer Biomarkers, CCBIO, Department of Clinical Science, Hematology Section, University of Bergen, 5021 Bergen, Norway
7,
Alastair M Thompson
Alastair M Thompson
8Department of Breast Surgical Oncology, MD Anderson Cancer Center, Holcombe Boulevard, Houston, 77030 USA
8,
Richard Svensson
Richard Svensson
9Department of Pharmacy, Uppsala University Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Department of Pharmacy, Uppsala University, SE-752 37 Uppsala, Sweden
9,
Anna-Lena Gustavsson
Anna-Lena Gustavsson
10Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 21 Stockholm, Sweden
10,
Lars Johansson
Lars Johansson
10Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 21 Stockholm, Sweden
10,
Katarina Färnegårdh
Katarina Färnegårdh
11Drug Discovery and Development Platform, Science for Life Laboratory, Tomtebodavägen 23, SE-171 21 Solna, Sweden
11,
Ulrika Yngve
Ulrika Yngve
12Department of Medicinal Chemistry, Science for Life Laboratories, Uppsala University, SE-751 23 Uppsala, Sweden
12,
Aljona Saleh
Aljona Saleh
12Department of Medicinal Chemistry, Science for Life Laboratories, Uppsala University, SE-751 23 Uppsala, Sweden
12,
Martin Haraldsson
Martin Haraldsson
11Drug Discovery and Development Platform, Science for Life Laboratory, Tomtebodavägen 23, SE-171 21 Solna, Sweden
11,
Agathe C A D’Hollander
Agathe C A D’Hollander
4School of Chemistry and Biomedical Sciences Research Complex, University of St. Andrews and EaStCHEM, St. Andrews, Fife, Scotland KY16 9ST UK
4,
Marcela Franco
Marcela Franco
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
1,
Yan Zhao
Yan Zhao
13Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle, NE1 7RU UK
13,
Maria Håkansson
Maria Håkansson
14SARomics Biostructures, Medicon Village, SE-223 81 Lund, Sweden
14,
Björn Walse
Björn Walse
14SARomics Biostructures, Medicon Village, SE-223 81 Lund, Sweden
14,
Karin Larsson
Karin Larsson
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
1,
Emma M Peat
Emma M Peat
15The Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, University of Edinburgh, Edinburgh, EH9 3JR UK
15,
Vicent Pelechano
Vicent Pelechano
2SciLifeLab, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Tomtebodavägen 23, SE-171 21 Stockholm, Sweden
2,
John Lunec
John Lunec
13Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle, NE1 7RU UK
13,
Borivoj Vojtesek
Borivoj Vojtesek
5RECAMO, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 65653 Brno, Czech Republic
5,
Mar Carmena
Mar Carmena
15The Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, University of Edinburgh, Edinburgh, EH9 3JR UK
15,
William C Earnshaw
William C Earnshaw
15The Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, University of Edinburgh, Edinburgh, EH9 3JR UK
15,
Anna R McCarthy
Anna R McCarthy
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
1,
Nicholas J Westwood
Nicholas J Westwood
4School of Chemistry and Biomedical Sciences Research Complex, University of St. Andrews and EaStCHEM, St. Andrews, Fife, Scotland KY16 9ST UK
4,
Marie Arsenian-Henriksson
Marie Arsenian-Henriksson
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
1,
David P Lane
David P Lane
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
2SciLifeLab, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Tomtebodavägen 23, SE-171 21 Stockholm, Sweden
1,2,
Ravi Bhatia
Ravi Bhatia
3Division of Hematology and Oncology, Comprehensive Cancer Center, 1720 2nd Avenue South, NP2540, Birmingham, AL 35294-3300 USA
3,
Emmet McCormack
Emmet McCormack
7Centre for Cancer Biomarkers, CCBIO, Department of Clinical Science, Hematology Section, University of Bergen, 5021 Bergen, Norway
16Department of Medicine, Haematology Section, Haukeland University Hospital, Bergen, Norway
7,16,
Sonia Laín
Sonia Laín
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
2SciLifeLab, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Tomtebodavägen 23, SE-171 21 Stockholm, Sweden
1,2,✉
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden
2SciLifeLab, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Tomtebodavägen 23, SE-171 21 Stockholm, Sweden
3Division of Hematology and Oncology, Comprehensive Cancer Center, 1720 2nd Avenue South, NP2540, Birmingham, AL 35294-3300 USA
4School of Chemistry and Biomedical Sciences Research Complex, University of St. Andrews and EaStCHEM, St. Andrews, Fife, Scotland KY16 9ST UK
5RECAMO, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 65653 Brno, Czech Republic
6Centre for Oncology and Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, Tayside DD1 9SY UK
7Centre for Cancer Biomarkers, CCBIO, Department of Clinical Science, Hematology Section, University of Bergen, 5021 Bergen, Norway
8Department of Breast Surgical Oncology, MD Anderson Cancer Center, Holcombe Boulevard, Houston, 77030 USA
9Department of Pharmacy, Uppsala University Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Department of Pharmacy, Uppsala University, SE-752 37 Uppsala, Sweden
10Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 21 Stockholm, Sweden
11Drug Discovery and Development Platform, Science for Life Laboratory, Tomtebodavägen 23, SE-171 21 Solna, Sweden
12Department of Medicinal Chemistry, Science for Life Laboratories, Uppsala University, SE-751 23 Uppsala, Sweden
13Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle, NE1 7RU UK
14SARomics Biostructures, Medicon Village, SE-223 81 Lund, Sweden
15The Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, University of Edinburgh, Edinburgh, EH9 3JR UK
16Department of Medicine, Haematology Section, Haukeland University Hospital, Bergen, Norway
© The Author(s) 2018
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.